EP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine
This episode was recorded live from the Ai4 conference podcast pavilion, Sam sat down with Alex Zhavoronkov, Founder & CEO of Insilico Medicine, about what it actually takes to turn AI-generated molecules into approved drugs. What's Covered: From Laughed-Out-of-the-Room to 33 Candidates — Alex pitched generative AI…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Inside AsembleAI: DeepTech, AI & Science
See all episodes →
EP 62: 95% of AI Pilots Fail. Here's Why | Mohamed Battisha, CTO at WEX
EP 61: "Shadow AI" — And No One's Watching | Rafi Khardalian, Actualyze AI
EP 60: Feeding the World with AI: Inside Syngenta's Data Playbook
Similar episodes from other shows
More like Inside AsembleAI: DeepTech, AI & Science →
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
#134 Alex Zhavoronkov: Unraveling AI's Crucial Role in Pharma
🔬 The Coolest Diffusion Research Isn't in LLMs — Evan Feinberg & Sergey Edunov, Genesis Molecular AI
Can America Win The AI Biotech Race Against China? | Lada Nuzhna & Elliot Hershberg
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.